APA Zitierstil

Qin, S., Chan, S. L., Sukeepaisarnjaroen, W., Han, G., Choo, S. P., Sriuranpong, V., . . . Tanwandee, T. (2019). A phase II study of the efficacy and safety of the MET inhibitor capmatinib (INC280) in patients with advanced hepatocellular carcinoma. Ther Adv Med Oncol.

Chicago Zitierstil

Qin, Shukui, et al. "A Phase II Study of the Efficacy and Safety of the MET Inhibitor Capmatinib (INC280) in Patients With Advanced Hepatocellular Carcinoma." Ther Adv Med Oncol 2019.

MLA Zitierstil

Qin, Shukui, et al. "A Phase II Study of the Efficacy and Safety of the MET Inhibitor Capmatinib (INC280) in Patients With Advanced Hepatocellular Carcinoma." Ther Adv Med Oncol 2019.

Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.